Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial
Clinical trial NCT04307329 · COMPLETED
Trial details
- NCT number
- NCT04307329
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2023-01-19
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.